Piotrowicz-Wójcik Katarzyna, Bulanda Małgorzata, Juchacz Aldona, Jamróz-Brzeska Joanna, Gocki Jacek, Kuziemski Krzysztof, Pawłowicz Robert, Porebski Grzegorz
Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, Botaniczna 3, 31-503 Krakow, Poland.
Greater Poland Center of Pulmonology and Thoracic Surgery, Szamarzewskiego 62, 60-569 Poznan, Poland.
J Clin Med. 2021 Nov 29;10(23):5609. doi: 10.3390/jcm10235609.
Hereditary angioedema (HAE) due to C1-inhibitor (C1-INH) deficiency is a rare disease characterized by recurrent swellings. This study aims to determine (i) the clinical characteristics of the HAE patient population from Poland, and (ii) real-life patients' treatment practices. A cross-sectional study involved 138 adult HAE patients (88 females, 50 males) treated in six regional HAE centers in Poland. Consecutive patients during routine follow-up visits underwent a structured medical interview on the clinical characteristics of the course and treatment of HAE attacks within the last six months. A total of 118 of 138 patients was symptomatic. They reported in total 2835 HAE attacks predominantly peripheral and abdominal, treated with plasma-derived C1-INH (61.4%), icatibant (36.7%) and recombinant C1-INH (1.9%). An amount of 116 patients carried the rescue medication with them while traveling, and 74 patients self-administrated on demand treatment. There were twice as many symptomatic women ( = 78) as there were men ( = 40). Women treated their HAE attacks significantly more often than men. Older patients (≥65 years) reported a longer delay in diagnosis, and practiced the self-administration of rescue medication less frequently in comparison to other patients. Clinical features of the surveyed population are similar to other European, but not Asian, HAE patient groups. Self-administration still remains an unmet medical need. Some distinct HAE patients may require special attention due to the severe course of the disease (females) or a delay in diagnosis (the elderly).
由于C1抑制剂(C1-INH)缺乏引起的遗传性血管性水肿(HAE)是一种以反复发作肿胀为特征的罕见疾病。本研究旨在确定:(i)波兰HAE患者群体的临床特征,以及(ii)现实生活中患者的治疗方法。一项横断面研究纳入了波兰六个地区HAE中心治疗的138例成年HAE患者(88例女性,50例男性)。在常规随访期间,连续的患者接受了关于过去六个月内HAE发作的病程和治疗的临床特征的结构化医学访谈。138例患者中有118例有症状。他们共报告了2835次HAE发作,主要发生在四肢和腹部,治疗方法主要有:血浆源性C1-INH(61.4%)、艾替班特(36.7%)和重组C1-INH(1.9%)。116例患者在旅行时随身携带急救药物,74例患者按需自行给药治疗。有症状的女性(=78)是男性(=40)的两倍。女性治疗HAE发作的频率明显高于男性。老年患者(≥65岁)报告诊断延迟时间更长,与其他患者相比,自行使用急救药物的频率更低。被调查人群的临床特征与其他欧洲HAE患者群体相似,但与亚洲患者群体不同。自行给药仍然是一项未满足的医疗需求。由于疾病病程严重(女性)或诊断延迟(老年人),一些特殊的HAE患者可能需要特别关注。